home · filing · 0001641172-25-014110
8-K
filed June 6, 2025, 7:59 PM ET
ticker BACK
CIK 0001729944
leadership
confidence high
sentiment neutral
materiality 0.45
IMAC Holdings appoints Jason Lobel and Saundra Pelletier to Board of Directors
IMAC Holdings, Inc.
Appointments effective June 2, 2025; both join as independent directors.
Jason Lobel is CEO/Co-Founder of GenomicMD and former CEO of SwiftIQ (AI/analytics).
Saundra Pelletier is former CEO of Evofem Biosciences, leader in women's health.
No family relationships or reportable transactions with existing officers/directors.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Jason Lobel
Director
BACK ·
IMAC Holdings, Inc.
Effective 2025-06-02
Filed June 6, 2025, 7:59 PM ET
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
Appointed
Saundra Pelletier
Director
BACK ·
IMAC Holdings, Inc.
Effective 2025-06-02
Filed June 6, 2025, 7:59 PM ET
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jason Lobel was appointed as Director at IMAC Holdings, Inc..
Action appointed
Role Director
Exact text from the filing
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Saundra Pelletier was appointed as Director at IMAC Holdings, Inc..
Action appointed
Role Director
Exact text from the filing
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001641172-25-014110
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.